<PAGE>


                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                  SCHEDULE 13D
                                 (Rule 13d-101)

    INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULE 13d-1(a)
               AND AMENDMENTS THERETO FILED PURSUANT RULE 13d-2(a)
                             (Amendment No. ____)/1/


                               E Med Future, Inc.
--------------------------------------------------------------------------------
                                (Name of Issuer)

                                  Common Stock
--------------------------------------------------------------------------------
                         (Title of Class of Securities)

                                    26875D108
--------------------------------------------------------------------------------
                                 (CUSIP Number)

    Christopher J. Hubbert, Kohrman Jackson & Krantz P.L.L., 1375 East 9/th/
                     Street, 20/th/ FL., Cleveland, OH 44114
--------------------------------------------------------------------------------
 (Name, Address and Telephone Number of Person Authorized to Receive Notices and
                                Communications)

                                  April 4, 2003
--------------------------------------------------------------------------------
             (Date of Event which Requires Filing of this Statement)

If the filing person has previously filed a statement on Schedule 13G to report
the acquisition which is the subject of this Schedule 13D, and is filing this
schedule because of Rule 13d-1(e), 13d-1(f) or 13d-1(g), check the following
box: [_]

                  Note: Schedules filed in paper format shall include a signed
         original and five copies of the schedule including all exhibits. See
         Rule 13d-7(b) for other parties to whom copies are to be sent.

_______________
/1/ The remainder of this cover page shall be filled out for a reporting
person's initial filing on this form with respect to the subject class of
securities, and for any subsequent amendment containing information which would
alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 or otherwise subject to the liabilities of that section of the Act but
shall be subject to all other provisions of the Act (however, see the Notes).

                                   Page 1 of 8

<PAGE>

                                  SCHEDULE 13D

CUSIP No. 26875D108                                                  Page 2 of 8

--------------------------------------------------------------------------------
 1  NAME OF REPORTING PERSON
    S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON

    Robert J. Ochsendorf
--------------------------------------------------------------------------------
 2  CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*              (a) [_]
                                                                   (b) [X]

--------------------------------------------------------------------------------
 3  SEC USE ONLY


--------------------------------------------------------------------------------
 4  SOURCE OF FUNDS

    OO
--------------------------------------------------------------------------------
 5  CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT
    TO ITEMS 2(d) OR 2(e)                                          [_]

--------------------------------------------------------------------------------
 6  CITIZENSHIP OR PLACE OF ORGANIZATION

    United States of America
--------------------------------------------------------------------------------
       NUMBER OF                   7      SOLE VOTING POWER

        SHARES                            2,500,000
                              --------------------------------------------------
     BENEFICIALLY                  8      SHARED VOTING POWER

       OWNED BY
                              --------------------------------------------------
         EACH                      9      SOLE DISPOSITIVE POWER

       REPORTING                          2,500,000
                              --------------------------------------------------
        PERSON                    10      SHARED DISPOSITIVE POWER

         WITH
--------------------------------------------------------------------------------
 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

    2,500,000
--------------------------------------------------------------------------------
 12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN
    SHARES                                                         [_]

--------------------------------------------------------------------------------
 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

    11.99%
--------------------------------------------------------------------------------
 14 TYPE OF REPORTING PERSON*

    IN
--------------------------------------------------------------------------------

<PAGE>

                                  SCHEDULE 13D

CUSIP No. 26875D108                                                  Page 3 of 8

--------------------------------------------------------------------------------
 1   NAME OF REPORTING PERSON
     S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON

     D. Dane Donohue
--------------------------------------------------------------------------------
 2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*             (a) [_]
                                                                   (b) [X]

--------------------------------------------------------------------------------
 3   SEC USE ONLY


--------------------------------------------------------------------------------
 4   SOURCE OF FUNDS

     OO
--------------------------------------------------------------------------------
 5   CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT
     TO ITEMS 2(d) OR 2(e)                                         [_]

--------------------------------------------------------------------------------
 6   CITIZENSHIP OR PLACE OF ORGANIZATION

     United States of America
--------------------------------------------------------------------------------
        NUMBER OF                   7      SOLE VOTING POWER

         SHARES                            2,500,000
                              --------------------------------------------------
      BENEFICIALLY                  8      SHARED VOTING POWER

        OWNED BY
                              --------------------------------------------------
          EACH                      9      SOLE DISPOSITIVE POWER

        REPORTING                          2,500,000
                              --------------------------------------------------
         PERSON                    10      SHARED DISPOSITIVE POWER

          WITH
--------------------------------------------------------------------------------
 11  AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     2,500,000
--------------------------------------------------------------------------------
 12  CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN
     SHARES                                                        [_]

--------------------------------------------------------------------------------
 13  PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

     11.99%
--------------------------------------------------------------------------------
 14  TYPE OF REPORTING PERSON*

     IN
--------------------------------------------------------------------------------

<PAGE>

                                  SCHEDULE 13D

CUSIP No. 26875D108                                                  Page 4 of 8

--------------------------------------------------------------------------------
 1   NAME OF REPORTING PERSON
     S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON

     Juan J. Perez
--------------------------------------------------------------------------------
 2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*             (a) [_]
                                                                   (c) [X]

--------------------------------------------------------------------------------
 3   SEC USE ONLY

--------------------------------------------------------------------------------
 4   SOURCE OF FUNDS

     OO
--------------------------------------------------------------------------------
 5   CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT
     TO ITEMS 2(d) OR 2(e)                                         [_]

--------------------------------------------------------------------------------
 6   CITIZENSHIP OR PLACE OF ORGANIZATION

     United States of America
--------------------------------------------------------------------------------
        NUMBER OF                   7      SOLE VOTING POWER

         SHARES                            625,000
                              --------------------------------------------------
      BENEFICIALLY                  8      SHARED VOTING POWER

        OWNED BY
                              --------------------------------------------------
          EACH                      9      SOLE DISPOSITIVE POWER

        REPORTING                          625,000
                              --------------------------------------------------
         PERSON                    10      SHARED DISPOSITIVE POWER

          WITH
--------------------------------------------------------------------------------
 11  AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     625,000
--------------------------------------------------------------------------------
 12  CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN
     SHARES                                                        [_]
--------------------------------------------------------------------------------
 13  PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

     3.0%
--------------------------------------------------------------------------------
 14  TYPE OF REPORTING PERSON*

     IN
--------------------------------------------------------------------------------

<PAGE>

CUSIP No. 26875D108                                                  Page 5 of 8

Item 1.     Security and Issuer.

         This original Schedule 13D Statement relates to shares of common stock,
par value $0.001 per share, of E Med Future, Inc., formerly Micro-Economics,
Inc., a Nevada corporation (the "Company"), which has its principal executive
offices at 794 Morrison Road Suite 911, Columbus, Ohio 43230.

Item 2.     Identity and Background.

       (a)  This Schedule 13D is filed by Robert J. Ochsendorf, D. Dane Donohue
and Juan J. Perez for the purpose of reporting acquisitions of shares of common
stock of the Company. Messrs. Ochsendorf, Donohue and Perez comprise the
Company's Board of Directors and Mr. Ochsendorf is President and Mr. Donohue is
Vice President of the Company.

       (b)  The business address of Messrs. Ochsendorf and Donohue is 794
Morrison Road Suite 911, Columbus, Ohio 43230. The business address of Mr. Perez
is 92 North Woods Blvd., Columbus, Ohio 43235.

       (c)  Mr. Ochsendorf's principal occupations are President and Chief
Executive Officer of E.R. Ochsendorf Company, a promotional advertising and
marketing company located at the address of the Company, and President of the
Company. Mr. Donohue's principal occupation is Vice President of the Company.
Mr. Perez's principal occupation is attorney and founder of Perez & Morris LLC,
a law firm located at 92 North Woods Blvd., Columbus, Ohio 43235.

       (d)  Negative with respect to Messrs. Ochsendorf, Donohue and Perez.

       (e)  Negative with respect to Messrs. Ochsendorf, Donohue and Perez.

       (f)  Messrs. Ochsendorf, Donohue and Perez are citizens of the United
States of America.

Item 3.     Source and Amount of Funds or Other Consideration.

       On April 2, 2003, the Company, then known as Micro-Economics, Inc.,
signed a definitive agreement and plan of merger with E Med Future, Inc., a
Delaware corporation ("E Med Delaware"), which is Exhibit 7.1 to this Schedule
13D and incorporated herein by reference. The merger was consummated on April 4,
2003. Pursuant to the terms of the merger agreement, shares of common stock and
preferred stock of E Med Delaware were converted into newly-issued shares of
common stock of the Company. As a result of the merger, E Med Delaware became a
wholly-owned subsidiary of the Company and its stockholders, including Messrs.
Ochsendorf, Donohue and Perez, received shares of common stock of the Company
equal to 95% of its outstanding capital stock. In addition, the Company changed
its corporate name to E Med Future, Inc. and the officers and directors of the
Company resigned. Messrs. Ochsendorf, Donohue and Perez were appointed directors
of the Company and Messrs. Ochsendorf and Donohue were appointed to serve the
Company as President and Executive Vice President, respectively.

<PAGE>

CUSIP No. 26875D108                                                  Page 6 of 8



Item 4.     Purpose of Transaction.

       The purpose of the transaction, as described in Item 3 and the merger
agreement, was to contribute the assets and business of E Med Delaware into the
publicly traded Company.

       Pursuant to the instructions for items (a) through (j) of Item 4 of
Schedule 13D, and except as described in Item 3, none of Messrs. Ochsendorf,
Donohue and Perez currently has plans or proposals that relate to or would
result in any of the following:

       (i)    an extraordinary corporate transaction, such as a merger,
reorganization or liquidation, involving the Company;

       (ii)   the sale or transfer of a material amount of assets of the
Company;

       (iii)  a change in the present board of directors or management of the
Company;

       (iv)   a material change in the present capitalization or dividend policy
of the Company;

       (v)    a material change in the business or corporate structure of the
Company;

       (vi)   a change to the articles of incorporation, as amended, or bylaws
of the Company, or an impediment to the acquisition of control of the Company,
by any person;

       (vii)  the delisting from the Nasdaq Stock Market's OTC Bulletin Board of
the Company's common stock;

       (viii) a class of equity securities of the Company; becoming eligible for
termination of registration pursuant to Section 12(g)(4) of the Securities
Exchange Act of 1934, as amended; or

       (ix)   any action similar to any of those enumerated in (i) through
(viii) above.

       Each of Messrs. Ochsendorf, Donohue and Perez reserves the right to
modify his plans and proposals described in this Item 4. Further, subject to
applicable laws and regulations, Messrs. Ochsendorf, Donohue and Perez may
formulate plans and proposals that may result in the occurrence of an event set
forth in (i) through (ix) above or in Item 4 of Schedule 13D.

Item 5.     Interest in Securities of the Issuer.

       (a)  As of April 4, 2003, there were 20,850,000 shares of common stock of
the Company outstanding.

       Mr. Ochsendorf beneficially owns 2,500,000 shares of common stock, or
approximately 11.99% of the outstanding common stock of the Company. Mr. Donohue
beneficially owns 2,500,000 shares of common stock, or approximately 11.99% of
the outstanding common stock of the Company. Mr. Perez beneficially owns 625,000
shares of common stock, or approximately 3.0% of the outstanding common stock of
the Company. Each of Messrs. Ochsendorf, Donohue and Perez disclaims beneficial
ownership of the shares of common stock held by each other.

<PAGE>

CUSIP No. 26875D108                                                  Page 7 of 8

       (b)  Each of Messrs. Ochsendorf, Donohue and Perez has sole power to
vote, or to direct the voting of, and sole power to dispose or to direct the
disposition of, the shares of common stock owned by him.

       (c)  Except as described in Item 4, none of the reporting persons has
effected any transactions in the common stock of the Company in the past 60
days.

       (d)  Not applicable.

       (e)  Not applicable.

Item 6.     Contracts, Arrangements, Understandings or Relationships With
            Respect to Securities of the Issuer.

       Not applicable.

Item 7.     Material to be Filed as Exhibits.

       Exhibit 7.1      Agreement and Plan of Merger dated as of April 2, 2003
                        between Micro-Economics, Inc., E Med Sub, Inc. and E Med
                        Future, Inc., incorporated by reference to Exhibit 2.1
                        to the Current Report on Form 8-K of the Company dated
                        April 4, 2003, filed with the Securities and Exchange
                        Commission on April 11, 2003.

       Exhibit 7.2      Joint Filing Agreement.

       After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.

Date:  April 25, 2003

                                                   /s/ Robert J. Ochsendorf
                                                  ------------------------------
                                                  Robert J. Ochsendorf

                                                   /s/ D. Dane Donohue
                                                  ------------------------------
                                                  D. Dane Donohue

                                                   /s/ Juan J. Perez
                                                  ------------------------------
                                                  Juan J. Perez

<PAGE>

                                                                     EXHIBIT 7.2

                            AGREEMENT OF JOINT FILING

      Pursuant to Rule 13d-1(k) promulgated under the Securities Exchange Act of
1934, as amended, the undersigned persons hereby agree to file with the
Securities and Exchange Commission, the Statement on Schedule 13D (the
"Statement") to which this Agreement is attached as an exhibit, and agree that
such Statement, as so filed, is filed on behalf of each of them.

      This Agreement may be executed in counterparts, each of which when so
executed shall be deemed to be an original, and all of which together shall be
deemed to constitute one and the same instrument.

      IN WITNESS WHEREOF, the undersigned have executed this Agreement.

Date:  April 25, 2003

                                                   /s/ Robert J. Ochsendorf
                                                  ------------------------------
                                                  Robert J. Ochsendorf

                                                   /s/ D. Dane Donohue
                                                  ------------------------------
                                                  D. Dane Donohue

                                                   /s/ Juan J. Perez
                                                  ------------------------------
                                                  Juan J. Perez

                                  Page 8 of 8

